Tissue repair & recoveryInjectable

KPV

Also known as: Lysine-Proline-Valine · α-MSH (11–13)

KPV is a short three-amino-acid peptide (lysine–proline–valine) derived from the tail end of the hormone α-MSH, studied for its possible role in calming inflammation.

Physician-reviewedDr. Bushra Mir, Medical Director · DHA-licensedReviewed 10 July 2026

The molecule, up close

Class: Tripeptide fragment of α-MSH
Origin: C-terminal fragment of alpha-melanocyte-stimulating hormone
Chemistry: 3 amino acids (Lys-Pro-Val)
Typical format: Injectable / topical
Regulatory status: Prescription-only; used under physician guidance

This page is educational information, not medical advice or an offer of treatment. Peptides used clinically are prescription medicines; whether any is appropriate for you is a decision a physician makes after a diagnostic assessment.

What it is

KPV is one of the smallest peptides in the conversation — just three amino acids taken from the end of α-MSH, a hormone involved in pigmentation and inflammation. It's of interest because the fragment appears to carry some of the parent hormone's anti-inflammatory signalling without its broader hormonal effects.

Its small size and its focus on inflammation are what set it apart from the tissue-repair peptides it's often grouped with. It remains an early-stage compound.

What it's studied for

Interest centres on inflammatory signalling in the gut and skin, and on how the body resolves inflammation rather than simply suppressing it. In the lab it's explored in models of inflammatory bowel conditions and skin inflammation.

These are research questions rather than established treatments. The honest framing is that KPV is being explored in inflammation biology, with the clinical picture still to be written.

The science

Laboratory work suggests KPV may act inside cells on the pathways that govern the inflammatory response, potentially dialling down the signalling that drives inflammation. Some research looks at how it's transported into cells to do this.

How well any of this translates to people, and at what exposure, isn't yet clear — the mechanism is still being studied rather than settled.

Typical form

Injectable

Shown in the dispensing format most often used in research and clinical settings. Where any protocol is appropriate, the route, dose and schedule are a physician’s decision — not a fixed recipe.

Safety & considerations

Prescription-only and physician-supervised where used. Because human data are limited, eligibility, dosing and monitoring are assessed individually, and treatable causes of inflammation should be looked at first.

As with any research peptide, product quality and sourcing are central safety concerns that a clinical setting is designed to control.

Status & oversight

KPV is a research peptide used under medical supervision rather than something for routine self-use. Clinical interest is early, and any use is individualised by a physician.

Common questions

KPV, in brief.

What is KPV studied for?

It's studied for inflammatory signalling, particularly in the gut and skin. This is an area of active research interest rather than an established treatment.

How is KPV different from α-MSH?

KPV is a small three-amino-acid fragment of the larger α-MSH hormone. It's of interest because it appears to carry some anti-inflammatory signalling without the fuller hormonal effects — though this is still being studied.

Is KPV a steroid or an anti-inflammatory drug?

No. It's a peptide fragment studied in inflammation biology, not a corticosteroid or an approved anti-inflammatory medicine, and it shouldn't be equated with either.

Can KPV be used on the skin?

Topical use is studied in research contexts, and any use would be physician-directed rather than an off-the-shelf skincare product.

Peptides of this kind are prescription medicines. Whether any protocol is appropriate is decided the way the rest of the practice works — from data, after an assessment.

How our longevity assessment works Back to the peptide field guide

How this is written

Physician-reviewed and evidence-led. We describe what a compound is studied for and where the evidence stands — not what it will do for you — and we revise pages as the science changes. Reviewed by Dr. Bushra Mir, Medical Director · DHA-licensed.

References

Peer-reviewed references for this compound are added by the physician author before publication.